Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ergoferon vs Oseltamivir in Influenza
NCT01850446Phase 4Completed
- Sponsor
- Materia Medica Holding
- Start
- Feb 2015
- Primary completion
- Apr 2018
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of Ergoferon in influenza, sponsored by Materia Medica Holding. Started Feb 2015; status: completed.
02
Drugs
Ergoferon
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01850446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01850446.